Massmutual Trust CO Fsb Supernus Pharmaceuticals, Inc. Transaction History
Massmutual Trust CO Fsb
- $3.51 Billion
- Q4 2024
A detailed history of Massmutual Trust CO Fsb transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 110 shares of SUPN stock, worth $4,306. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110
Previous 110
-0.0%
Holding current value
$4,306
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SUPN
# of Institutions
284Shares Held
60.5MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$407 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$240 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$200 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$113 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$103 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.09B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...